193 related articles for article (PubMed ID: 21320077)
1. CXCL13 chemokine in pediatric and adult neuroborreliosis.
Wutte N; Berghold A; Löffler S; Zenz W; Daghofer E; Krainberger I; Kleinert G; Aberer E
Acta Neurol Scand; 2011 Nov; 124(5):321-8. PubMed ID: 21320077
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
6. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
8. The chemokine CXCL13 in acute neuroborreliosis.
Senel M; Rupprecht TA; Tumani H; Pfister HW; Ludolph AC; Brettschneider J
J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):929-33. PubMed ID: 19965843
[TBL] [Abstract][Full Text] [Related]
9. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
10. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.
Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J
Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846
[TBL] [Abstract][Full Text] [Related]
11. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.
Wagner JN; Weis S; Kubasta C; Panholzer J; von Oertzen TJ
J Neurol; 2018 Jan; 265(1):74-81. PubMed ID: 29134272
[TBL] [Abstract][Full Text] [Related]
12. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
13. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
Tumani H; Cadavid D
Neurology; 2011 Mar; 76(12):1034-5. PubMed ID: 21422454
[No Abstract] [Full Text] [Related]
14. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis.
Widhe M; Skogman BH; Jarefors S; Eknefelt M; Eneström G; Nordwall M; Ekerfelt C; Croner S; Bergström S; Forsberg P; Ernerudh J
Int Immunol; 2005 Oct; 17(10):1283-91. PubMed ID: 16176932
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
Pietikäinen A; Oksi J; Hytönen J
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
[TBL] [Abstract][Full Text] [Related]
19. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
[TBL] [Abstract][Full Text] [Related]
20. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
